Womens and health professionals preferences for prenatal tests for Down syndrome: A discrete choice experiment to contrast noninvasive prenatal diagnosis with current invasive tests

Genetics in Medicine

Volumn 14, Issue 11, 2012, Pages 905-913

  Hill, Melissa ^a,b   Fisher, Jane ^c   Chitty, Lyn S ^a,b   Morris, Stephen ^b,d  

^a UNIVERSITY COLLEGE LONDON   (United Kingdom)

^b UNIVERSITY COLLEGE LONDON HOSPITALS   (United Kingdom)

^c Antenatal Results and Choices   (United Kingdom)

^d UNIVERSITY COLLEGE LONDON   (United Kingdom)

Author keywords

discrete choice experiment; Down syndrome; non invasive prenatal diagnosis

Indexed keywords

ADULT; ARTICLE; CONTROLLED STUDY; COUNSELING; DIAGNOSTIC ACCURACY; DIAGNOSTIC TEST; DOWN SYNDROME; FEMALE; HEALTH CARE POLICY; HEALTH PRACTITIONER; HUMAN; MAJOR CLINICAL STUDY; PREGNANCY; PRENATAL DIAGNOSIS; QUESTIONNAIRE; SPONTANEOUS ABORTION; SUPPORT GROUP; WOMEN'S HEALTH; COMPARATIVE STUDY; DECISION MAKING; HEALTH CARE PERSONNEL; METHODOLOGY; PATIENT PREFERENCE; PSYCHOLOGICAL ASPECT; REPRODUCIBILITY; RISK FACTOR; STATISTICAL MODEL; TIME; UNITED KINGDOM;

ABORTION, SPONTANEOUS; ADULT; CHOICE BEHAVIOR; DOWN SYNDROME; ENGLAND; FEMALE; HEALTH PERSONNEL; HUMANS; LOGISTIC MODELS; PATIENT PREFERENCE; PREGNANCY; PRENATAL DIAGNOSIS; QUESTIONNAIRES; REPRODUCIBILITY OF RESULTS; RISK FACTORS; TIME FACTORS; YOUNG ADULT;

EID: 84869014216     PISSN: 10983600     EISSN: 15300366     Source Type: Journal    
DOI: 10.1038/gim.2012.68     Document Type: Article

References (42)

1. Mujezinovic F, Alfirevic Z. Procedure-related complications of amniocentesis and chorionic villous sampling: a systematic review. Obstet Gynecol 2007;110:687-694. (Pubitemid 47359597)
2. Lo YM, Corbetta N, Chamberlain PF, et al. Presence of fetal DNA in maternal plasma and serum. Lancet 1997;350:485-487. (Pubitemid 27343304)
3. Lo YM, Hjelm NM, Fidler C, et al. Prenatal diagnosis of fetal RhD status by molecular analysis of maternal plasma. N Engl J Med 1998;339:1734-1738. (Pubitemid 28555431)
4. Lo YM, Zhang J, Leung TN, Lau TK, Chang AM, Hjelm NM. Rapid clearance of fetal DNA from maternal plasma. Am J Hum Genet 1999;64:218-224. (Pubitemid 30428975)
5. Lo YM, Tein MS, Lau TK, et al. Quantitative analysis of fetal DNA in maternal plasma and serum: implications for noninvasive prenatal diagnosis. Am J Hum Genet 1998;62:768-775. (Pubitemid 28194317)
6. Chiu RW, Akolekar R, Zheng YW, et al. Non-invasive prenatal assessment of trisomy 21 by multiplexed maternal plasma DNA sequencing: large scale validity study. BMJ 2011;342:c7401.
7. Palomaki GE, Kloza EM, Lambert-Messerlian GM, et al. DNA sequencing of maternal plasma to detect Down syndrome: an international clinical validation study. Genet Med 2011;13:913-920.
8. Bianchi DW, Platt LD, Goldberg JD, Abuhamad AZ, Sehnert AJ, Rava RP. Genome-wide fetal aneuploidy detection by maternal plasma DNA sequencing. Obstet Gynecol 2012;119:890-901.
9. Sequenom. http://www.sequenomcmm.com/home/, 2011.
10. Chitty LS, Hill M, White H, Wright D, Morris S. Noninvasive prenatal testing for aneuploidy-ready for prime time? Am J Obstet Gynecol 2012;206:269-275.
11. Benn P, Borrell A, Cuckle H, et al. Prenatal Detection of Down Syndrome using Massively Parallel Sequencing (MPS): a rapid response statement from a committee on behalf of the Board of the International Society for Prenatal Diagnosis, 24 October 2011. Prenat Diagn 2011; 32:1-2.
12. de Bekker-Grob EW, Ryan M, Gerard K. Discrete choice experiments in health economics: a review of the literature. Health Econ 2012;21:145-172.
13. Ryan M, Gerard K, Amaya-Amaya M (eds). Using Discrete Choice Experiments to Value Health and Health Care. Springer: Dordrecht, The Netherlands, 2008.
14. Bishop AJ, Marteau TM, Armstrong D, et al. Women and health care professionals' preferences for Down's Syndrome screening tests: a conjoint analysis study. BJOG 2004;111:775-779. (Pubitemid 39061498)
15. Lewis SM, Cullinane FM, Carlin JB, Halliday JL. Women's and health professionals' preferences for prenatal testing for Down syndrome in Australia. Aust N Z J Obstet Gynaecol 2006;46:205-211. (Pubitemid 44056727)
16. Lewis SM, Cullinane FN, Bishop AJ, Chitty LS, Marteau TM, Halliday JL. A comparison of Australian and UK obstetricians' and midwives' preferences for screening tests for Down syndrome. Prenat Diagn 2006; 26:60-66. (Pubitemid 43189334)
17. Ryan M, Diack J, Watson V, Smith N. Rapid prenatal diagnostic testing for Down syndrome only or longer wait for full karyotype: the views of pregnant women. Prenat Diagn 2005;25:1206-1211. (Pubitemid 43164741)
18. Chan YM, Sahota DS, Leung TY, Choy KW, Chan OK, Lau TK. Chinese women's preferences for prenatal diagnostic procedure and their willingness to trade between procedures. Prenat Diagn 2009;29:1270-1276.
19. Lancsar E, Louviere J. Conducting discrete choice experiments to inform healthcare decision making: a user's guide. Pharmacoeconomics 2008;26:661-677. (Pubitemid 351989058)
20. Bridges JF, Hauber AB, Marshall D, et al. Conjoint analysis applications in health-a checklist: a report of the ISPOR Good Research Practices for Conjoint Analysis Task Force. Value Health 2011;14:403-413.
21. Street D, Burgess L, Viney R, Louviere J. Designing discete choice experiments for health care. In: Ryan M, Gerard K, Amaya-Amaya M (eds). Using Discrete Choice Experiments to Value Health and Health Care. Springer: Dordrecht, The Netherlands, 2008:47-72.
22. Hahn G, Shapiro S. A Catalogue and Computer Program for the Design and Analysis of Orthoganol Symmetric and Asymmetric Fractional Factorial Experiments. General Electric Research and Development Center: Schenectady, New York, 1966.
23. Street D, Burgess L. Discrete Choice Experiments (computer software). University of Technology: Sydney, 2007. http://crsu.science.uts.edu.au/choice/. Accessed October 2011.
24. McFadden D. Conditional logit analysis of qualitative choice behavior. In: Zarembka P (ed). Frontiers in Econometrics. Academic Press: New York, 1974:105-142.
25. Haaijer R, Kamakura W, Wedel M. The "no-choice" alternative in conjoint choice experiments. Int J Res Mark 2001;43:93-106.
26. Wright CF. Cell-free Fetal Nucleic Acids for Non-invasive Prenatal Diagnosis. Report of the UK Expert Working Group. PHG Foundation [online], 2009. http://www.phgfoundation.org/reports/4985.
27. Benn PA, Chapman AR. Practical and ethical considerations of noninvasive prenatal diagnosis. JAMA 2009;301:2154-2156.
28. de Jong A, Dondorp WJ, de Die-Smulders CE, Frints SG, de Wert GM. Non-invasive prenatal testing: ethical issues explored. Eur J Hum Genet 2010;18:272-277.
29. de Jong A, Dondorp WJ, Frints SG, de Die-Smulders CE, de Wert GM. Advances in prenatal screening: the ethical dimension. Nat Rev Genet 2011;12:657-663.
30. Deans Z, Newson AJ. Should non-invasiveness change informed consent procedures for prenatal diagnosis? Health Care Anal 2011;19: 122-132.
31. Etchegary H, Potter B, Howley H, et al. The influence of experiential knowledge on prenatal screening and testing decisions. Genet Test 2008;12:115-124. (Pubitemid 351457786)
32. Mulvey S, Zachariah R, McIlwaine K, Wallace EM. Do women prefer to have screening tests for Down syndrome that have the lowest screen-positive rate or the highest detection rate? Prenat Diagn 2003;23:828-832. (Pubitemid 37279869)
33. Tischler R, Hudgins L, Blumenfeld YJ, Greely HT, Ormond KE. Noninvasive prenatal diagnosis: pregnant women's interest and expected uptake. Prenat Diagn 2011;31:1292-1299.
34. Lewis C, Hill M, Skirton H, Chitty L. Fetal sex determination using free fetal DNA: Service users' experiences and preferences for how the service should be offered in clinical practice. Prenat Diagn 2012; e-pub ahead of print 10 May 2012.
35. Newson AJ. Ethical aspects arising from non-invasive fetal diagnosis. Semin Fetal Neonatal Med 2008;13:103-108.
36. van den Heuvel A, Chitty L, Dormandy E, et al. Will the introduction of non-invasive prenatal diagnostic testing erode informed choices? An experimental study of health care professionals. Patient Educ Couns 2010;78:24-28.
37. Lehoux P, Denis JL, Rock M, Hivon M, Tailliez S. How medical specialists appraise three controversial health innovations: scientific, clinical and social arguments. Sociol Health Illn 2010;32:123-139.
38. Grosse SD, Rogowski WH, Ross LF, Cornel MC, Dondorp WJ, Khoury MJ. Population screening for genetic disorders in the 21st century: evidence, economics, and ethics. Public Health Genomics 2010;13:106-115.
39. Dormandy E, Marteau TM. Uptake of a prenatal screening test: the role of healthcare professionals' attitudes towards the test. Prenat Diagn 2004;24:864-868. (Pubitemid 39576799)
40. Fisher J. First-trimester screening: dealing with the fall-out. Prenat Diagn 2011;31:46-49.
41. Fisher J. Supporting patients after disclosure of abnormal first trimester screening results. Curr Opin Obstet Gynecol 2012;24:109-113.
42. Bot-Robin V, Sendon S, Bourzoufi K, et al. Maternal anxiety and pain during prenatal diagnostic techniques: a prospective study. Prenat Diagn 2012;32:562-568.